“Safety in Switching from Innovator Adalimumab to Its Biosimilar and from Biosimilar to Biosimilar”. Universitas Scientiarum (November 5, 2025): S24. Accessed November 10, 2025. https://revistas.javeriana.edu.co/index.php/scientarium/article/view/41559.